- Axonics, founded in 2012 and based in Irvine, CA, specializes in bioelectronic medicine and neurostimulation, particularly with its Axonics Sacral Neuromodulation System that addresses bladder and bowel dysfunction, positioning itself in a market projected to reach $1.4 billion by 2028.
- In November 2024, Axonics was acquired by Boston Scientific for $3.41 billion, enhancing its capabilities and market reach in the medical technology sector.
- The company has established partnerships with healthcare providers and hospitals, focusing on delivering innovative solutions for patients suffering from urinary and bowel disorders, with a notable success rate where 92% of women report improvement after treatment.
- Axonics' ideal buyers are healthcare institutions and professionals treating patients with overactive bladder and fecal incontinence, as their products provide long-lasting, clinically proven therapies that significantly improve patient quality of life.
Sales and Support is the largest group, accounting for about one-third of all employees with 183 team members dedicated to commercial outreach, training, and field assistance. Healthcare specialists—including clinical affairs and medical professionals—form the next-largest segment at 168 employees, highlighting the company’s need for deep therapeutic knowledge. Core product innovation is driven by a 32-person Engineering team, complemented by 28 people in Marketing and Product who guide go-to-market strategy. Operations, Finance & Administration, and Human Resources collectively total just over 60 employees, providing the infrastructure required to scale, while 45 staff are classified in Other roles, reflecting a diverse range of support functions.
Axonics’ workforce is widely distributed, with 387 employees listed under "Other" locations that include remote and field-based roles. The corporate headquarters in Irvine, California hosts 45 employees, serving as the primary hub for engineering, quality, and leadership functions. Additional concentrations appear across Southern California—15 employees in Orange County and 15 in Los Angeles—along with smaller pockets in New York, St. Louis, Santa Ana, Nashville, and Tampa, each housing fewer than ten employees. This geographic spread underscores the field-oriented nature of medical-device commercialization, ensuring clinical and sales support is available near key markets and healthcare providers.
